Previous Page  22 / 42 Next Page
Information
Show Menu
Previous Page 22 / 42 Next Page
Page Background

Notes:

Page 78

CNS 2016

December 05-07, 2016

Volume 7, Issue 5(Suppl)

J Neurol Neurophysiol

ISSN: 2155-9562 JNN, an open access journal

conferenceseries

.com

December 05-07, 2016 Dubai, UAE

2

nd

International Conference on

Central Nervous System Disorders & Therapeutics

Hussein Algahtani et al., J Neurol Neurophysiol 2016, 7:5(Suppl)

http://dx.doi.org/10.4172/2155-9562.C1.041

Urea cycle disorder misdiagnosed as multiple sclerosis: A case report

Hussein Algahtani, Yousef Marzouk, Hind Abobaker and Bader Shirah

King Saud bin Abdulaziz University for Health Sciences, KSA

U

rea cycle disorders (UCD) are a collection of inborn errors of metabolism caused by dysfunction of any of the six enzymes

or two transport proteins involved in urea biosynthesis. Urea cycle is the final pathway for nitrogen metabolism and

dysfunction of this important pathway cause UCD, which are more common during the neonatal period. The suspicion for this

metabolic disorder arises when patients present with elevated blood ammonia level and neurological manifestation without

underlying hepatocellular dysfunction. In this article, we report a patient who presented with neurological dysfunction and

coma in the immediate postpartum period. She was misdiagnosed for many years as a case of demyelinating disorder. The

diagnosis was confirmed based on the presence of urine orotic acid and elevated certain serum amino acid levels. Hemodialysis

was performed to the patient to correct the hyperammonemic-related dysfunction which was unresponsive to conventional

measures. She improved gradually with repeated hemodialysis and made a full recovery. Her clinical and radiological status has

not changed for five years since diagnosis was made. The importance of reporting this case is to illustrate that wrong diagnosis

of patients as being affected with multiple sclerosis for many years due to MRI abnormalities rather than classical relapsing

remitting nature of the disease may lead to grave consequences. In addition, the patient was treated with intravenous steroids

several times which is contraindicated in patients with UCD as it may precipitate acute hyperammonemic attacks. We believe

that the presence of symmetrical hyperintense insular cortical changes is pathognomonic for UCD. This radiological sign is

extremely rare and seldom reported in the literature.

Biography

Hussein Algahtani is the Associate Dean of clinical affairs and the Head of the simulation Center in the College of Medicine at King Saud bin Abdulaziz University for

Health Sciences in Jeddah, Saudi Arabia. He is also an Assistant Professor in Neurology and the neurosciences block coordinator. In addition, he is the Neurology

section Head and the Head of Neurophysiology laboratory at King Abdulaziz medical city in Jeddah, Saudi Arabia. He is a well-known researcher with more than

50 publications in the literature.

halgahtani@hotmail.com